V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20030251 | 20012904 | 1.64 | null | Adjuvant (A) | 2013-05-28 | 2013-06-04 | FEC + DOCETAXEL | 2 | N | 20106502 | FEC + DOCETAXEL |
| 20030252 | 20012904 | 1.69 | 65.7 | Neo-adjuvant (N) | 2014-10-21 | 2014-10-25 | FEC + DOCETAXEL | 02 | N | 20106502 | FEC + DOCETAXEL |
| 20030253 | 20012905 | 1.62 | 72.2 | Adjuvant (A) | 2013-03-11 | 2013-03-28 | FEC + DOCETAXEL | N | N | 20106508 | FEC + DOCETAXEL |
| 20030254 | 20072807 | 1.52 | 67.6 | Adjuvant (A) | 2014-08-21 | 2014-09-02 | FEC + DOCETAXEL | 2 | N | 20106516 | FEC + DOCETAXEL |
| 20030255 | 20072807 | 1.73 | 62 | Adjuvant (A) | 2014-07-20 | 2014-08-01 | FEC + DOCETAXEL | N | N | 20106516 | FEC + DOCETAXEL |
| 20030256 | 20072807 | 1.74 | 73 | Adjuvant (A) | 2015-03-18 | 2015-04-01 | FEC + DOCETAXEL | 02 | Y | 20106516 | FEC + DOCETAXEL |
| 20030257 | 20012906 | 1.56 | 60.4 | Adjuvant (A) | 2016-09-09 | 2016-09-12 | FEC + DOCETAXEL | 02 | N | 20106529 | FEC + DOCETAXEL |
| 20030258 | 20012906 | 1.7 | 79.4 | Adjuvant (A) | 2014-08-09 | 2014-08-16 | FEC 100 + DOCETAXEL | N | N | 20106529 | FEC + DOCETAXEL |
| 20030259 | 20012907 | 1.64 | 63 | Adjuvant (A) | 2017-04-25 | 2017-04-26 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20106531 | FEC + DOCETAXEL |
| 20030260 | 20012907 | null | 82.7 | Adjuvant (A) | 2014-03-02 | 2014-03-07 | FEC + DOCETAXEL | N | N | 20106531 | FEC + DOCETAXEL |
| 20030261 | 20012908 | 1.63 | null | Palliative (P) | null | 2014-07-14 | FEC + DOCETAXEL | N | N | 20106535 | FEC + DOCETAXEL |
| 20030262 | 20012909 | 1.58 | 63.6 | Not known (9) | 2013-09-11 | 2013-09-13 | FEC + DOCETAXEL | 02 | N | 20106538 | FEC + DOCETAXEL |
| 20030263 | 20012909 | null | 62.7 | Adjuvant (A) | 2017-08-27 | 2017-09-06 | FEC 60 OR 75 + DOCETAXEL | N | N | 20106538 | FEC + DOCETAXEL |
| 20030264 | 20012910 | 1.73 | 71.8 | Adjuvant (A) | 2016-12-20 | 2017-01-05 | FEC + DOCETAXEL | N | N | 20106547 | FEC + DOCETAXEL |
| 20030265 | 20012910 | null | null | Adjuvant (A) | 2013-11-15 | 2013-11-15 | FEC + DOCETAXEL | null | null | 20106547 | FEC + DOCETAXEL |
| 20030266 | 20012910 | 1.67 | 57.2 | null | 2016-11-13 | 2016-11-13 | FEC + DOCETAXEL | N | N | 20106547 | FEC + DOCETAXEL |
| 20030267 | 20012911 | 1.68 | 67.5 | Neo-adjuvant (N) | 2014-10-10 | 2014-10-11 | FEC + DOCETAXEL | 2 | null | 20106571 | FEC + DOCETAXEL |
| 20030268 | 20012911 | 1.65 | 66.5 | Disease modification (D) | 2015-01-01 | 2015-01-10 | FEC + DOCETAXEL | 02 | N | 20106571 | FEC + DOCETAXEL |
| 20030269 | 20012912 | 1.62 | 70.9 | Curative (C) | 2017-11-22 | 2017-12-08 | FEC + DOCETAXEL | N | N | 20106578 | FEC + DOCETAXEL |
| 20030270 | 20012913 | 1.64 | 64.3 | Adjuvant (A) | null | 2016-08-23 | FEC 100 + DOCETAXEL | N | N | 20106585 | FEC + DOCETAXEL |
| 20030271 | 20012913 | 1.73 | 57 | Adjuvant (A) | null | 2015-12-01 | FEC + DOCETAXEL | N | N | 20106585 | FEC + DOCETAXEL |
| 20030272 | 20012914 | 1.71 | 62.55 | Neo-adjuvant (N) | 2018-01-25 | 2018-01-25 | FEC 100 + DOCETAXEL | 02 | N | 20106595 | FEC + DOCETAXEL |
| 20030273 | 20012914 | 1.62 | 66 | Adjuvant (A) | 2017-11-20 | 2018-01-09 | FEC 100 + DOCETAXEL | N | N | 20106595 | FEC + DOCETAXEL |
| 20030274 | 20012914 | 1.68 | 75.2 | Neo-adjuvant (N) | 2015-05-27 | 2015-06-04 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20106595 | FEC + DOCETAXEL |
| 20030275 | 20012915 | 1.72 | 71 | Disease modification (D) | null | 2014-07-03 | FEC 100 + DOCETAXEL | N | N | 20106613 | FEC + DOCETAXEL |
| 20030276 | 20012915 | 1.56 | 86 | Neo-adjuvant (N) | 2016-12-16 | 2016-12-17 | FEC + DOCETAXEL | 2 | N | 20106613 | FEC + DOCETAXEL |
| 20030277 | 20012915 | 0 | 56 | Adjuvant (A) | 2016-08-28 | 2016-09-01 | FEC + DOCETAXEL | 02 | N | 20106613 | FEC + DOCETAXEL |
| 20030278 | 20012915 | 1.72 | 80 | Adjuvant (A) | 2017-04-04 | 2017-04-04 | FEC + DOCETAXEL | 02 | N | 20106613 | FEC + DOCETAXEL |
| 20030279 | 20012915 | 1.72 | 72.4 | Neo-adjuvant (N) | 2014-01-16 | 2014-01-16 | FEC + DOCETAXEL | 2 | N | 20106613 | FEC + DOCETAXEL |
| 20030280 | 20012916 | 1.6 | 71.3 | Adjuvant (A) | null | 2014-05-02 | FEC + DOCETAXEL | N | N | 20106631 | FEC + DOCETAXEL |
| 20030281 | 20012916 | 1.66 | null | Adjuvant (A) | 2013-05-17 | 2013-05-24 | FEC + DOCETAXEL | 99 | null | 20106631 | FEC + DOCETAXEL |
| 20030282 | 20012916 | 1.57 | 86 | Not known (9) | 2013-04-25 | 2013-05-03 | FEC + DOCETAXEL | 02 | N | 20106631 | FEC + DOCETAXEL |
| 20030283 | 20012916 | 1.55 | 58 | Neo-adjuvant (N) | null | 2013-07-04 | FEC + DOCETAXEL | N | N | 20106631 | FEC + DOCETAXEL |
| 20030284 | 20012916 | 1.6 | 77 | Adjuvant (A) | 2013-12-20 | 2013-12-20 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20106631 | FEC + DOCETAXEL |
| 20030285 | 20012916 | 1.71 | 64.8 | Adjuvant (A) | 2015-12-30 | 2015-12-30 | FEC + DOCETAXEL | 2 | N | 20106631 | FEC + DOCETAXEL |
| 20030286 | 20012916 | null | 66.7 | Neo-adjuvant (N) | 2015-04-29 | 2015-05-02 | FEC + DOCETAXEL | N | N | 20106631 | FEC + DOCETAXEL |
| 20030287 | 20147358 | 1.6 | null | Palliative (P) | null | 2016-09-26 | FEC 100 + DOCETAXEL | N | null | 20106660 | FEC + DOCETAXEL |
| 20030288 | 20147358 | 1.6 | 61 | Adjuvant (A) | 2013-11-09 | 2013-11-20 | FEC 100 + DOCETAXEL | 02 | N | 20106660 | FEC + DOCETAXEL |
| 20030289 | 20147358 | null | null | Adjuvant (A) | 2016-11-09 | 2016-11-15 | FEC 100 + DOCETAXEL | 2 | N | 20106660 | FEC + DOCETAXEL |
| 20030290 | 20012917 | 1.63 | null | Adjuvant (A) | 2015-03-06 | 2015-03-28 | FEC + DOCETAXEL | N | N | 20106666 | FEC + DOCETAXEL |
| 20030291 | 20012917 | 1.69 | 68 | Adjuvant (A) | 2017-08-11 | 2017-08-18 | FEC 100 + DOCETAXEL | 02 | N | 20106666 | FEC + DOCETAXEL |
| 20030292 | 20012917 | 1.55 | 121 | Adjuvant (A) | null | 2017-12-05 | FEC + DOCETAXEL | N | null | 20106666 | FEC + DOCETAXEL |
| 20030293 | 20012917 | 1.7 | 104 | Adjuvant (A) | 2015-12-25 | 2016-01-30 | FEC + DOCETAXEL | 02 | N | 20106666 | FEC + DOCETAXEL |
| 20030294 | 20012918 | 1.76 | 63.6 | Adjuvant (A) | 2013-07-05 | 2013-07-05 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | Y | 20106687 | FEC + DOCETAXEL |
| 20030295 | 20012918 | 1.61 | 90.1 | Adjuvant (A) | null | 2016-09-28 | FEC + DOCETAXEL | 02 | N | 20106687 | FEC + DOCETAXEL |
| 20030296 | 20012919 | 1.67 | 62.7 | Adjuvant (A) | 2014-05-29 | 2014-06-14 | FEC + DOCETAXEL | 2 | N | 20106689 | FEC + DOCETAXEL |
| 20030297 | 20012919 | 1.56 | 58 | Adjuvant (A) | 2014-10-30 | 2014-11-20 | FEC 100 + DOCETAXEL | N | N | 20106689 | FEC + DOCETAXEL |
| 20030298 | 20012919 | 1.52 | 74.6 | Disease modification (D) | 2014-03-05 | 2014-03-05 | FEC 100 + DOCETAXEL | 2 | N | 20106689 | FEC + DOCETAXEL |
| 20030299 | 20012919 | 1.72 | 65 | Adjuvant (A) | 2013-05-07 | 2013-05-23 | FEC 100 + DOCETAXEL | null | N | 20106689 | FEC + DOCETAXEL |
| 20030300 | 20012920 | 1.71 | 69.2 | Adjuvant (A) | 2015-09-02 | 2015-09-11 | FEC + DOCETAXEL | 02 | N | 20106702 | FEC + DOCETAXEL |